Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 73 clinical trials
D-Dimer Guided Oral Anticoagulant Treatment (OAT)

This clinical trial will investigate the hypothesis that D-Dimer testing can be successfully used to tailor the duration of OAT in patients after an unprovoked episode of deep venous

d-dimer
anticoagulants
venous thrombosis
warfarin
deep vein thrombosis
  • 15 views
  • 07 Nov, 2020
  • 1 location
Assessing Safety Hospitalization and Efficacy of rNAPc2 in COVID-19

-inflammatory and potential antiviral properties, shortens time to recovery compared to heparin in hospitalized patients with COVID-19 and elevated D-dimer levels.

  • 0 views
  • 12 Sep, 2021
  • 13 locations
The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots

undergo phlebotomy (blood draw) at baseline (prior to insertion of the IUD), two and four months. Stored samples will be used to measure D-dimer, C-reactive protein (CRP), antithrombin (AT

d-dimer
protein c
thrombin
levonorgestrel
thrombosis
  • 146 views
  • 07 Nov, 2020
  • 1 location
ANTIcoagulation in Severe COVID-19 Patients

, high-dose prophylactic anticoagulation (HD-PA) and therapeutic anticoagulation (TA) can be employed either empirically or based on the body mass index and increased D-dimer values. No randomized trial

  • 0 views
  • 25 Jul, 2021
  • 1 location
Efficacy Safety Tolerability and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS

The study aims to evaluate MN-166 (ibudilast) in patients with COVID-19 who are at risk of developing acute respiratory distress syndrome. Subjects will be screened, randomly assigned to MN-166 or placebo groups, receive study drug on Days 1-7, and followed up on Day 14 and Day 28.

  • 0 views
  • 13 Aug, 2021
  • 2 locations
Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19

An open label clinical study to evaluate the safety and the efficacy of MesenCure, an allogeneic cell therapy product, for the treatment of the pulmonary manifestations in COVID19 patients

  • 12 views
  • 11 Jul, 2021
  • 1 location
COVID-19 Methylene Blue Antiviral Treatment

This is a pilot study of a single-center, blind, randomized, placebo-controlled, parallel-group study testing for the efficacy and safety of Methylene blue when administered topically as a 0.02% solution for nasopharyngeal and oropharyngeal irrigation in COVID-19 patients requiring hospitalization.

  • 0 views
  • 23 Aug, 2021
  • 1 location
Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19

Clinical, control, double-blind, randomized trial with tenofovir disoproxyl fumarate and emtricitabine for Covid-19

  • 0 views
  • 01 Feb, 2021
  • 1 location
Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus

To date, some of the most promising drugs used in the treatment of COVID pneumonia are systemic corticosteroids, remdesivir and baricitinib. Dexamethasone has been found efficacious in reducing mortality in patients requiring supplemental oxygen and mechanical ventilation. There is a trend towards reduced mortality in patients who receive remdesivir and …

  • 1 views
  • 01 Sep, 2021
  • 12 locations
An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization

The purpose of this Clinical trial is to explore the therapeutic benefits of Ivermectin and Doxycycline in different combinations in high risk patients diagnosed with COVID-19.

  • 0 views
  • 09 Apr, 2021
  • 1 location